BLUEJET Stock Overview
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 6/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Blue Jet Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹683.55 |
| 52 Week High | ₹968.30 |
| 52 Week Low | ₹347.60 |
| Beta | 0 |
| 1 Month Change | -18.89% |
| 3 Month Change | 17.57% |
| 1 Year Change | 77.20% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 65.35% |
Recent News & Updates
Recent updates
Calculating The Fair Value Of Blue Jet Healthcare Limited (NSE:BLUEJET)
Mar 08
After Leaping 26% Blue Jet Healthcare Limited (NSE:BLUEJET) Shares Are Not Flying Under The Radar
Feb 03
New Capacity And R&D Investments Will Meet Future Customer Demand
Feb 02 New capacity and strategic expansions are set to sustain production and boost revenue by meeting increasing customer demand efficiently.Blue Jet Healthcare Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Feb 01Here's Why We Think Blue Jet Healthcare (NSE:BLUEJET) Is Well Worth Watching
Jan 31Revenue Miss: Blue Jet Healthcare Limited Fell 13% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Aug 10Blue Jet Healthcare Limited's (NSE:BLUEJET) Price In Tune With Earnings
Jul 26Blue Jet Healthcare's (NSE:BLUEJET) Solid Earnings May Rest On Weak Foundations
Jun 02Blue Jet Healthcare Limited Just Missed Earnings - But Analysts Have Updated Their Models
May 30Shareholder Returns
| BLUEJET | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 4.2% | 2.3% | 3.2% |
| 1Y | 77.2% | 11.4% | -1.1% |
Return vs Industry: BLUEJET exceeded the Indian Pharmaceuticals industry which returned 10.5% over the past year.
Return vs Market: BLUEJET exceeded the Indian Market which returned -2.4% over the past year.
Price Volatility
| BLUEJET volatility | |
|---|---|
| BLUEJET Average Weekly Movement | 9.5% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.9% |
Stable Share Price: BLUEJET's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: BLUEJET's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 447 | Shiven Arora | www.bluejethealthcare.com |
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts.
Blue Jet Healthcare Limited Fundamentals Summary
| BLUEJET fundamental statistics | |
|---|---|
| Market cap | ₹118.57b |
| Earnings (TTM) | ₹2.35b |
| Revenue (TTM) | ₹8.73b |
50.5x
P/E Ratio13.6x
P/S RatioIs BLUEJET overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BLUEJET income statement (TTM) | |
|---|---|
| Revenue | ₹8.73b |
| Cost of Revenue | ₹4.01b |
| Gross Profit | ₹4.73b |
| Other Expenses | ₹2.38b |
| Earnings | ₹2.35b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 30, 2025
| Earnings per share (EPS) | 13.53 |
| Gross Margin | 54.15% |
| Net Profit Margin | 26.88% |
| Debt/Equity Ratio | 0.1% |
How did BLUEJET perform over the long term?
See historical performance and comparisonDividends
0.1%
Current Dividend Yield11%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/14 06:11 |
| End of Day Share Price | 2025/04/11 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Blue Jet Healthcare Limited is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shashank Krishnakumar | Emkay Global Financial Services Ltd. |
| Sanjesh Jain | ICICI Securities Ltd. |
| Bansi Desai | J.P. Morgan |